Uranium Roe vs Price To Sales Ratio Analysis

UROY Stock

USD 2.19 0.06 2.82%

Uranium Royalty financial indicator trend analysis is much more than just breaking down Uranium Royalty Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Uranium Royalty Corp is a good investment. Please check the relationship between Uranium Royalty Roe and its Price To Sales Ratio accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Uranium Royalty Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Roe vs Price To Sales Ratio

Roe vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Uranium Royalty Corp Roe account and Price To Sales Ratio. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Uranium Royalty's Roe and Price To Sales Ratio is -0.62. Overlapping area represents the amount of variation of Roe that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Uranium Royalty Corp, assuming nothing else is changed. The correlation between historical values of Uranium Royalty's Roe and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Roe of Uranium Royalty Corp are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Roe i.e., Uranium Royalty's Roe and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

-0.62

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Roe

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Uranium Royalty Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Uranium Royalty sales, a figure that is much harder to manipulate than other Uranium Royalty Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Uranium Royalty's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Uranium Royalty Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Uranium Royalty Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

At this time, Uranium Royalty's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 44.34 in 2024, whereas Selling General Administrative is likely to drop slightly above 3.1 M in 2024.

Uranium Royalty fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Current Deferred Revenue	Other Assets	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets
Total Assets		0.19	0.3	1.0	0.99	-0.57	0.49	0.94	0.91	0.89	-0.36	0.76	0.91	-0.94	0.41	1.0	1.0	-0.67	0.33	-0.84	0.84	0.84	-0.32	-0.74	0.97	0.36
Other Current Liab	0.19		0.99	0.16	0.21	0.33	-0.18	0.28	0.12	0.29	-0.35	0.39	0.3	-0.25	0.76	0.17	0.17	0.08	-0.14	-0.06	-0.05	0.07	0.07	-0.12	0.09	0.12
Total Current Liabilities	0.3	0.99		0.26	0.3	0.25	-0.09	0.39	0.23	0.37	-0.35	0.45	0.38	-0.34	0.77	0.28	0.28	-0.01	-0.11	-0.14	0.06	0.14	0.0	-0.2	0.2	0.13
Total Stockholder Equity	1.0	0.16	0.26		0.98	-0.6	0.52	0.94	0.93	0.88	-0.33	0.74	0.9	-0.93	0.37	1.0	1.0	-0.69	0.33	-0.84	0.85	0.84	-0.35	-0.75	0.97	0.34
Net Tangible Assets	0.99	0.21	0.3	0.98		-0.5	0.36	0.9	0.88	0.94	-0.5	0.83	0.94	-0.98	0.46	0.97	0.99	-0.66	0.43	-0.89	0.74	0.89	-0.18	-0.76	0.92	0.49
Net Debt	-0.57	0.33	0.25	-0.6	-0.5		-0.72	-0.61	-0.81	-0.36	-0.22	-0.15	-0.41	0.4	0.48	-0.59	-0.59	0.79	-0.08	0.51	-0.73	-0.5	0.75	0.73	-0.67	0.26
Retained Earnings	0.49	-0.18	-0.09	0.52	0.36	-0.72		0.61	0.6	0.1	0.63	-0.14	0.18	-0.18	-0.3	0.55	0.49	-0.42	-0.4	-0.1	0.88	0.11	-0.92	-0.26	0.68	-0.54
Accounts Payable	0.94	0.28	0.39	0.94	0.9	-0.61	0.61		0.92	0.8	-0.2	0.69	0.85	-0.83	0.36	0.95	0.94	-0.77	0.27	-0.76	0.88	0.76	-0.52	-0.76	0.93	0.17
Cash	0.91	0.12	0.23	0.93	0.88	-0.81	0.6	0.92		0.78	-0.21	0.63	0.81	-0.82	0.13	0.92	0.92	-0.83	0.26	-0.8	0.84	0.79	-0.55	-0.88	0.92	0.1
Non Current Assets Total	0.89	0.29	0.37	0.88	0.94	-0.36	0.1	0.8	0.78		-0.7	0.93	0.99	-0.98	0.57	0.86	0.9	-0.65	0.61	-0.93	0.54	0.95	0.03	-0.78	0.76	0.63
Non Currrent Assets Other	-0.36	-0.35	-0.35	-0.33	-0.5	-0.22	0.63	-0.2	-0.21	-0.7		-0.84	-0.63	0.64	-0.65	-0.29	-0.36	0.21	-0.76	0.67	0.2	-0.65	-0.67	0.44	-0.12	-0.87
Cash And Short Term Investments	0.76	0.39	0.45	0.74	0.83	-0.15	-0.14	0.69	0.63	0.93	-0.84		0.89	-0.89	0.68	0.71	0.76	-0.59	0.74	-0.9	0.33	0.87	0.22	-0.72	0.57	0.7
Common Stock Shares Outstanding	0.91	0.3	0.38	0.9	0.94	-0.41	0.18	0.85	0.81	0.99	-0.63	0.89		-0.97	0.53	0.88	0.91	-0.69	0.57	-0.92	0.59	0.95	-0.07	-0.8	0.79	0.59
Other Stockholder Equity	-0.94	-0.25	-0.34	-0.93	-0.98	0.4	-0.18	-0.83	-0.82	-0.98	0.64	-0.89	-0.97		-0.54	-0.92	-0.94	0.62	-0.52	0.92	-0.61	-0.92	0.02	0.76	-0.84	-0.62
Total Liab	0.41	0.76	0.77	0.37	0.46	0.48	-0.3	0.36	0.13	0.57	-0.65	0.68	0.53	-0.54		0.37	0.39	0.09	0.25	-0.32	0.03	0.33	0.43	-0.07	0.25	0.57
Total Current Assets	1.0	0.17	0.28	1.0	0.97	-0.59	0.55	0.95	0.92	0.86	-0.29	0.71	0.88	-0.92	0.37		1.0	-0.66	0.27	-0.8	0.87	0.8	-0.37	-0.72	0.98	0.31
Common Stock	1.0	0.17	0.28	1.0	0.99	-0.59	0.49	0.94	0.92	0.9	-0.36	0.76	0.91	-0.94	0.39	1.0		-0.69	0.34	-0.85	0.83	0.85	-0.32	-0.76	0.97	0.37
Short Long Term Debt Total	-0.67	0.08	-0.01	-0.69	-0.66	0.79	-0.42	-0.77	-0.83	-0.65	0.21	-0.59	-0.69	0.62	0.09	-0.66	-0.69		-0.56	0.81	-0.63	-0.79	0.49	0.92	-0.63	-0.11
Current Deferred Revenue	0.33	-0.14	-0.11	0.33	0.43	-0.08	-0.4	0.27	0.26	0.61	-0.76	0.74	0.57	-0.52	0.25	0.27	0.34	-0.56		-0.76	-0.03	0.73	0.42	-0.54	0.13	0.7
Other Assets	-0.84	-0.06	-0.14	-0.84	-0.89	0.51	-0.1	-0.76	-0.8	-0.93	0.67	-0.9	-0.92	0.92	-0.32	-0.8	-0.85	0.81	-0.76		-0.51	-0.98	0.02	0.89	-0.7	-0.6
Net Receivables	0.84	-0.05	0.06	0.85	0.74	-0.73	0.88	0.88	0.84	0.54	0.2	0.33	0.59	-0.61	0.03	0.87	0.83	-0.63	-0.03	-0.51		0.52	-0.73	-0.54	0.93	-0.13
Common Stock Total Equity	0.84	0.07	0.14	0.84	0.89	-0.5	0.11	0.76	0.79	0.95	-0.65	0.87	0.95	-0.92	0.33	0.8	0.85	-0.79	0.73	-0.98	0.52		-0.03	-0.86	0.71	0.61
Short Term Investments	-0.32	0.07	0.0	-0.35	-0.18	0.75	-0.92	-0.52	-0.55	0.03	-0.67	0.22	-0.07	0.02	0.43	-0.37	-0.32	0.49	0.42	0.02	-0.73	-0.03		0.33	-0.5	0.68
Non Current Liabilities Total	-0.74	-0.12	-0.2	-0.75	-0.76	0.73	-0.26	-0.76	-0.88	-0.78	0.44	-0.72	-0.8	0.76	-0.07	-0.72	-0.76	0.92	-0.54	0.89	-0.54	-0.86	0.33		-0.66	-0.29
Inventory	0.97	0.09	0.2	0.97	0.92	-0.67	0.68	0.93	0.92	0.76	-0.12	0.57	0.79	-0.84	0.25	0.98	0.97	-0.63	0.13	-0.7	0.93	0.71	-0.5	-0.66		0.17
Other Current Assets	0.36	0.12	0.13	0.34	0.49	0.26	-0.54	0.17	0.1	0.63	-0.87	0.7	0.59	-0.62	0.57	0.31	0.37	-0.11	0.7	-0.6	-0.13	0.61	0.68	-0.29	0.17

Click cells to compare fundamentals

Uranium Royalty Account Relationship Matchups

Uranium Royalty fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	70.7M	76.2M	178.2M	185.8M	278.7M	292.6M
Total Current Liabilities	399.6K	506.9K	486K	10.3M	2.8M	3.4M
Total Stockholder Equity	70.2M	75.6M	164.6M	175.4M	275.8M	289.6M
Net Tangible Assets	70.2M	75.6M	164.6M	175.4M	201.7M	211.8M
Net Debt	(11.8M)	(7.2M)	8.7M	(4.4M)	(20.9M)	(19.9M)
Retained Earnings	(6.8M)	(7.9M)	(12.1M)	(11.9M)	22.5M	23.6M
Accounts Payable	399.6K	506.9K	469K	549K	1.2M	1.3M
Cash	11.8M	7.2M	4.4M	14.3M	21.1M	22.2M
Non Current Assets Total	27.3M	25.6M	44.1M	47.0M	47.0M	32.2M
Non Currrent Assets Other	(27.3M)	(25.6M)	(44.1M)	(47.0M)	(1.0)	(1.05)
Cash And Short Term Investments	42.3M	37.3M	56.2M	52.6M	30.2M	39.5M
Common Stock Shares Outstanding	54.3M	72.0M	88.3M	97.9M	115.3M	75.4M
Other Stockholder Equity	(60.0M)	(71.5M)	(140.3M)	(155.4M)	(139.9M)	(132.9M)
Total Liab	439.6K	546.9K	13.5M	10.4M	2.9M	2.8M
Total Current Assets	43.4M	50.6M	134.0M	138.8M	231.8M	243.3M
Common Stock	66.8M	73.0M	152.4M	167.3M	244.4M	256.6M
Net Receivables	351.4K	211.0	2.1M	110K	14.3M	15.0M
Short Term Investments	30.5M	30.0M	51.8M	38.3M	9.1M	8.7M
Liabilities And Stockholders Equity	70.7M	76.2M	178.2M	185.8M	278.7M	152.9M
Other Current Assets	752.3K	31.0M	47.7M	32.7M	110K	104.5K
Net Invested Capital	70.2M	75.7M	177.6M	175.4M	275.8M	150.0M
Accumulated Other Comprehensive Income	3.1M	4.2M	24.3M	19.9M	8.9M	11.4M
Capital Stock	66.8M	73.0M	152.4M	167.3M	244.4M	134.6M
Net Working Capital	43.0M	50.1M	133.5M	128.5M	229.0M	240.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Uranium Stock Analysis

When running Uranium Royalty's price analysis, check to measure Uranium Royalty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Uranium Royalty is operating at the current time. Most of Uranium Royalty's value examination focuses on studying past and present price action to predict the probability of Uranium Royalty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Uranium Royalty's price. Additionally, you may evaluate how the addition of Uranium Royalty to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Uranium Roe vs Price To Sales Ratio Analysis

Roe vs Price To Sales Ratio

Roe vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Roe

Price To Sales Ratio

Uranium Royalty fundamental ratios Correlations

Uranium Royalty Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Uranium Royalty fundamental ratios Accounts

Also Currently Popular

Additional Tools for Uranium Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Common Stock	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Stockholder Equity
Common Stock	+ 1.0	Total Stockholder Equity
Common Stock	+ 1.0	Total Current Assets

Common Stock Total Equity	- 0.98	Other Assets
Other Stockholder Equity	- 0.98	Non Current Assets Total
Other Stockholder Equity	- 0.98	Net Tangible Assets
Other Stockholder Equity	- 0.97	Common Stock Shares Outstanding
Common Stock	- 0.94	Other Stockholder Equity
Other Stockholder Equity	- 0.94	Total Assets